Fabianna Tennant

Fabianna is a recent graduate of the University of Manchester, where she gained a first-class BSc honours degree in Biochemistry with a one-year placement at the Skeletal Diseases Lab, The University of L’Aquila, L’Aquila, Italy.  She was awarded the University of Manchester J.P. Dancer Prize for the highest final year project score and the Biological Sciences Poster Prize by The University of L’Aquila Department of Biotechnological and Applied Clinical Sciences.  Fabianna brings her diverse research experience is looking forward to learning all about target safety assessments and ion channel screening.

Magali-Anne Maizieres

MSc

Magali is an electrophysiologist and gained 3 years’ laboratory experience in both manual and automated patch-clamp at Sanofi.  After completing a BSc in Life Sciences form the University Pierre and Marie Curies in Paris and BSc in Biotechnologies from the University Paris Descartes, Magali gained a Master’s degree in Health Technologies from the University of Bordeaux. Magali subsequently joined Horizon Discovery, gaining experience in engineering cell lines, and then Cambridge University as a RA in neuroscience.   Magali joined ApconiX to indulge her love of patch-clamp and her passion for ion channels and electrophysiology.

Nicholas Coltman

PhD

Nic recently completed his PhD in in vitro pre-clinical toxicological research (hepatotoxicity, genotoxicity, advanced in vitro models) through a BBSRC iCASE Scholarship with Sygnature Discovery Ltd at the University of Birmingham.  Before this, Nic gained a master’s degree in molecular mechanistic toxicology and a post graduate certificate in advanced research methods and skills before gaining invaluable industry experience first at Envigo and then at Sygnature Discovery.  A creative a skilled scientific professional, Nic brings innovative new thinking to the team, alongside a solid knowledge of molecular and mechanistic toxicology.

Peter Cotton

Peter is an expert clinical pathologist specialist with over 30 years of experience in big pharma.  Until recently Peter was the Chairperson of the Association for Comparative Clinical Pathology and associate editor of the Journal for Comparative Clinical Pathology.  Keeping up the tradition of many of the ApconiX team, Peter is a lecturer on the MSc Toxicology courses at the University of Birmingham and the University of Surrey.  With an excellent understanding of non-clinical study design and interpretation, Pete can propose solutions in response to complex data sets to ensure good outcomes.

Pauline Garner

Pauline is an experienced Genetic Toxicologist with over 24 years in non-clinical safety at a medium-sized CRO. Specialising in Programme Management for the last 9 years, Pauline combines a passion for science and pharmaceutical development, with the knowledge of project and commercial needs.  Pauline has a strong reputation in communication and an eye for detail.  She particularly enjoys building enduring customer relationships to support optimum delivery of non-clinical safety programmes.

Emily Johnson

PhD

After completing her BSc Neuroscience (1^st class, Hons), Emily studied the role of T-type Ca²⁺ channels in proliferative cardiovascular disease for her PhD (University of Leeds). Having cemented a love for electrophysiology, she spent 5 years working as a post-doctoral Research Fellow, utilising her expertise with patch-clamp electrophysiology, optogenetics and 2-photon Ca²⁺ imaging, to address novel Neuroscience research questions.  A natural problem solver and collaborative researcher, Emily has a tenacious attitude useful for acquiring high-quality, reproducible data.

Helen Garside

PhD

Helen has over 10 years’ experience in the pharmaceutical industry focused on predictive and mechanistic toxicology.  She has expertise in early project toxicology gained through roles in discovery safety and safety pharmacology, supporting projects across multiple therapy areas. Helen has a passion for collaborative working and applying the latest technology to toxicology.

Louisa Lake

Louisa has worked for over 18 years in a customer facing role.  A natural relationship builder, Louisa is process driven, communicative, supportive, and thorough.  She is a great addition to the expanding ApconiX team.

Sean Hammond

PhD

Sean holds a PhD in immuno-pharmacology from the University of Liverpool, focused on developing experimental and conceptual means to address T-cell mediated hypersensitivity reactions. He has long-standing links with drug safety research at Liverpool; having received the Syngenta prize for Pharmacology at degree level, and maintains an academic profile. He has several publications focused on the immuno-toxicological aspects of small molecular weight compounds and immune-checkpoint inhibitors. Sean particularly values integrating the approaches of inter-disciplinary experts in order to drive knowledge-based decision-making in drug development projects from inception to clinical delivery.

Read more here